1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Obstructive Lung Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, SR; Cunningham, FM; Hammond, A; Marr, CM | 1 |
| Cunningham, FM; Dunkel, B; Page, CP; Rickards, KJ | 1 |
| Barnes, NC | 1 |
| Cunningham, FM; Fairbairn, SM; Lees, P; Marr, KA; Page, CP | 1 |
| Bai, TR; Jacobson, MA; Knight, DA; Salvatore, CA; Walker, BA; Weir, T; Zhou, D | 1 |
| Ablett, JM; Cunningham, FM; Fairbairn, SM; Lees, P; Page, CP | 1 |
| Beadle, RE; Holmes, EP; Seahorn, TL; Venugopalan, CS | 1 |
| Beusenberg, FD; Bonta, IL; Brouwers, JW; Hekking, PR; Hoogsteden, HC; Schermers, HP; Van Amsterdam, JG | 1 |
| Alving, K; Lundberg, JM; Matran, R | 1 |
| Brigham, KL | 1 |
| Hahn, HL | 1 |
| Schilling, W; Slapke, J | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Obstructive Lung Diseases
| Article | Year |
|---|---|
New developments in the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Asthma; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Lung Diseases, Obstructive; Platelet Activating Factor; Thromboxanes | 1993 |
[Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Humans; Leukotrienes; Lung Diseases, Obstructive; Platelet Activating Factor; Prostaglandin D2; Theophylline | 1988 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Obstructive Lung Diseases
| Article | Year |
|---|---|
Platelets in equine recurrent airway obstruction.
Topics: Animals; Antigens; Blood Platelets; Horse Diseases; Horses; Hypersensitivity; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thromboxanes; Time Factors | 2007 |
Platelet activation in ponies with airway inflammation.
Topics: Acid Phosphatase; Animals; Antigens; Blood Platelets; Dose-Response Relationship, Drug; Horse Diseases; Horses; Hypersensitivity; Interleukin-8; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Thrombin | 2007 |
Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease.
Topics: Analysis of Variance; Animals; Azepines; Blood Platelets; Eosinophils; Heart Rate; Horse Diseases; Horses; Indium Radioisotopes; Leukocyte Count; Lung Diseases, Obstructive; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pleura; Pressure; Reference Values; Respiration; Respiratory Function Tests; Time Factors; Triazoles | 1996 |
Adenosine A3 receptor expression and function in eosinophils.
Topics: Adenosine; Animals; Bronchi; Cells, Cultured; Chemotaxis, Leukocyte; Eosinophils; Gene Expression Regulation; Humans; Hypersensitivity, Immediate; Iodobenzenes; Lung; Lung Diseases, Obstructive; Mesoderm; Molecular Sequence Data; Platelet Activating Factor; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Sheep; Xanthines | 1997 |
Influence of antigen challenge on platelet responsiveness in horses with chronic obstructive pulmonary disease.
Topics: Adenosine Diphosphate; Allergens; Animals; Antigens; Blood Platelets; Horse Diseases; Horses; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Poaceae; Time Factors | 1997 |
Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Dinoprostone; Guinea Pigs; Histamine; Horse Diseases; Horses; In Vitro Techniques; Leukotriene D4; Lung; Lung Diseases, Obstructive; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Poaceae; Prostaglandin Antagonists; Quinolines; Reference Values; Seasons; Trachea; Xanthenes; Xanthones | 1998 |
Stimulation of cyclic AMP production in human alveolar macrophages induced by inflammatory mediators and beta-sympathicomimetics.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Cyclic AMP; Dinoprostone; Female; Histamine; Humans; Isoproterenol; Lung Diseases, Obstructive; Macrophages, Alveolar; Male; Middle Aged; Platelet Activating Factor; Smoking | 1992 |
Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig.
Topics: Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bronchi; Capsaicin; Histamine Antagonists; Lung Diseases, Obstructive; Nedocromil; Nose; Platelet Activating Factor; Quinolones; Regional Blood Flow; Swine; Vasodilation | 1991 |
Conference summary: lipid mediators in the pulmonary circulation.
Topics: Animals; Bronchopulmonary Dysplasia; Eicosanoic Acids; Humans; Infant, Newborn; Lung; Lung Diseases, Obstructive; Neutrophils; Platelet Activating Factor; Pulmonary Circulation; Superoxides | 1987 |
[Arachidonic acid metabolism and chronic obstructive respiratory tract diseases: pathologic effects and perspectives for therapy].
Topics: Arachidonic Acid; Arachidonic Acids; Bronchi; Humans; Lung Diseases, Obstructive; Phospholipases A; Platelet Activating Factor | 1988 |